Ekso Bionics (EKSO) Short Interest Ratio & Short Volume $0.69 -0.03 (-4.16%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Ekso Bionics Short Interest DataEkso Bionics (EKSO) has a short interest of 73,800 shares. This marks a -47.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 114,774 shares to cover all short positions.Current Short Interest73,800 sharesPrevious Short Interest141,400 sharesChange Vs. Previous Month-47.81%Dollar Volume Sold Short$63,172.80Short Interest Ratio0.9 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares21,998,000 sharesPercentage of Shares Shorted0.34%Today's Trading Volume130,733 sharesAverage Trading Volume114,774 sharesToday's Volume Vs. Average114% Short Selling Ekso Bionics? Sign up to receive the latest short interest report for Ekso Bionics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEKSO Short Interest Over TimeEKSO Days to Cover Over TimeEKSO Percentage of Float Shorted Over Time Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Ekso Bionics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202473,800 shares $63,172.80 -47.8%N/A0.9 $0.86 10/15/2024141,400 shares $149,884.00 -28.0%N/A1.6 $1.06 9/30/2024196,300 shares $227,708.00 +1.4%N/A2.2 $1.16 9/15/2024193,600 shares $237,160.00 -46.4%N/A2.2 $1.23 8/31/2024360,900 shares $433,080.00 +393.7%N/A4.3 $1.20 8/15/202473,100 shares $65,095.55 +52.0%N/A0.9 $0.89 Get the Latest News and Ratings for EKSO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202448,100 shares $50,505.00 -57.2%N/A0.7 $1.05 7/15/2024112,500 shares $154,125.00 -19.4%N/A2.1 $1.37 6/30/2024139,500 shares $147,172.50 +65.9%N/A2.2 $1.06 6/15/202484,100 shares $88,725.50 -28.4%N/A1.2 $1.06 5/31/2024117,500 shares $135,125.00 -27.7%N/A1.5 $1.15 5/15/2024162,600 shares $221,136.00 -26.9%N/A1.2 $1.36 4/30/2024222,300 shares $275,652.00 +16.8%N/A1.6 $1.24 4/15/2024190,300 shares $274,032.00 +41.7%N/A1.1 $1.44 3/31/2024134,300 shares $182,648.00 +20.8%N/A0.7 $1.36 3/15/2024111,200 shares $146,784.00 -23.4%N/A0.5 $1.32 2/29/2024145,100 shares $275,690.00 -15.7%N/A0.7 $1.90 2/15/2024172,100 shares $351,084.00 -32.0%N/A1 $2.04 1/31/2024253,000 shares $579,370.00 -32.2%N/A1.4 $2.29 1/15/2024373,300 shares $623,411.00 +44.8%N/A2.3 $1.67 12/31/2023257,900 shares $644,750.00 -13.9%2.2%2.1 $2.50 12/15/2023299,600 shares $401,464.00 +206.0%2.6%3.5 $1.34 11/30/202397,900 shares $171,325.00 +37.7%0.8%1.3 $1.75 11/15/202371,100 shares $98,829.00 +109.7%0.6%1 $1.39 10/31/202333,900 shares $36,951.00 -2.3%0.3%0.5 $1.09 10/15/202334,700 shares $26,996.60 -13.7%0.3%0.7 $0.78 9/30/202340,200 shares $29,466.60 -45.8%0.4%0.8 $0.73 9/15/202374,200 shares $53,898.88 +105.5%0.7%1.5 $0.73 8/31/202336,100 shares $32,500.83 +32.7%0.3%0.7 $0.90 8/15/202327,200 shares $29,648.00 -14.5%0.2%0.6 $1.09 7/31/202331,800 shares $36,888.00 -10.4%0.3%0.9 $1.16 7/15/202335,500 shares $42,955.00 -28.7%0.3%1.3 $1.21 6/30/202349,800 shares $71,214.00 +45.6%0.4%1.9 $1.43 6/15/202334,200 shares $46,512.00 -2.3%0.3%1.3 $1.36 5/31/202335,000 shares $47,250.00 -4.1%0.3%1.4 $1.35 5/15/202336,500 shares $59,860.00 +9.6%0.3%1.6 $1.64 4/30/202333,300 shares $49,617.00 -19.2%0.3%1.4 $1.49 4/15/202341,200 shares $64,684.00 +5.4%0.4%1.7 $1.57 3/31/202339,100 shares $64,515.00 -20.4%0.3%1.2 $1.65 3/15/202349,100 shares $69,722.00 +1.9%0.4%1.5 $1.42Trump Wins… But Elon Says Get Ready to Brace (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 2/28/202348,200 shares $68,926.00 -3.6%0.4%1.1 $1.43 2/15/202350,000 shares $85,900.00 -0.4%0.4%1 $1.72 1/31/202350,200 shares $84,838.00 -26.8%0.5%1 $1.69 1/15/202368,600 shares $121,422.00 +36.4%0.6%1.3 $1.77 12/30/202250,300 shares $59,857.00 -41.8%0.5%1 $1.19 12/15/202286,400 shares $120,096.00 +100.0%0.8%1.9 $1.39 11/30/202243,200 shares $44,928.00 -11.8%0.4%1.1 $1.04 11/15/202249,000 shares $63,700.00 -20.3%0.4%1.6 $1.30 10/31/202261,500 shares $101,475.00 -18.4%0.5%1.7 $1.65 10/15/202275,400 shares $107,068.00 -11.3%0.7%1.9 $1.42 9/30/202285,000 shares $132,600.00 -10.7%0.7%2.2 $1.56 9/15/202295,200 shares $205,632.00 +2.7%0.8%2 $2.16 8/31/202292,700 shares $217,845.00 +27.0%0.8%0.2 $2.35 8/15/202273,000 shares $181,770.00 -43.6%0.6%0.1 $2.49 7/31/2022129,400 shares $227,744.00 -4.3%1.1%0.2 $1.76 7/15/2022135,200 shares $229,569.60 -7.4%1.2%0.2 $1.70 6/30/2022146,000 shares $240,900.00 -77.7%1.3%0.3 $1.65 6/15/2022655,700 shares $1.23 million +1,322.3%5.6%1.2 $1.88 5/31/202246,100 shares $87,590.00 -20.5%0.4%1.1 $1.90 5/15/202258,000 shares $101,494.20 -11.3%0.5%1.3 $1.75 4/30/202265,400 shares $148,458.00 -15.5%0.6%1.5 $2.27 4/15/202277,400 shares $208,980.00 +14.8%0.7%1.8 $2.70 3/31/202267,400 shares $194,786.00 -3.3%N/A1.4 $2.89 3/15/202269,700 shares $179,826.00 +1.2%0.6%1.1 $2.58 2/28/202268,900 shares $179,140.00 -7.8%0.6%0.9 $2.60 2/15/202274,700 shares $194,220.00 -28.5%0.6%0.9 $2.60 1/31/2022104,400 shares $252,648.00 -11.1%0.8%1.1 $2.42 1/15/2022117,400 shares $297,022.00 +8.1%N/A1 $2.53 12/31/2021108,600 shares $287,790.00 -26.2%0.9%0.9 $2.65 12/15/2021147,100 shares $436,887.00 -11.0%1.2%1.4 $2.97 11/30/2021165,300 shares $537,225.00 -15.1%1.3%1.3 $3.25 11/15/2021194,800 shares $748,032.00 -3.6%1.6%1.6 $3.84 10/29/2021202,000 shares $812,040.00 +42.8%1.6%1.7 $4.02 10/15/2021141,500 shares $582,980.00 +9.7%1.1%1.4 $4.12 9/30/2021129,000 shares $595,980.00 -21.3%1.0%1.3 $4.62 9/15/2021164,000 shares $675,680.00 -8.6%1.3%1.6 $4.12 8/31/2021179,500 shares $858,010.00 -21.9%1.5%2.1 $4.78 8/13/2021229,800 shares $1.10 million -15.8%1.9%2.3 $4.79 7/30/2021272,900 shares $1.33 million +34.9%2.2%1.7 $4.86 7/15/2021202,300 shares $942,718.00 -4.9%1.6%1.1 $4.66 6/30/2021212,800 shares $1.17 million +33.2%1.7%0.9 $5.50 6/15/2021159,800 shares $872,508.00 -40.7%1.3%0.5 $5.46 5/28/2021269,500 shares $1.53 million -30.8%2.2%0.8 $5.68 5/14/2021389,300 shares $1.95 million -0.1%3.2%1.1 $5.02 4/30/2021389,800 shares $2.00 million +36.2%3.2%0.7 $5.12 4/15/2021286,200 shares $1.85 million +67.4%N/A0 $6.48 3/31/2021171,000 shares $1.01 million -5.9%1.5%0.3 $5.90 3/15/2021181,800 shares $1.33 million -5.7%1.6%0.4 $7.30 2/26/2021192,800 shares $1.38 million -6.3%1.7%0.5 $7.16 2/12/2021205,700 shares $1.98 million -1.5%1.9%0.6 $9.61Trump Wins… But Elon Says Get Ready to Brace (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 1/29/2021208,800 shares $1.94 million -15.5%2.8%0.8 $9.30 1/15/2021247,000 shares $1.99 million +31.4%3.3%1.5 $8.04 12/31/2020188,000 shares $1.17 million +28.9%2.5%1.4 $6.22 12/15/2020145,900 shares $752,844.00 -16.9%2.0%1.4 $5.16 11/30/2020175,500 shares $1.00 million +7.1%2.4%2 $5.72 11/15/2020163,800 shares $753,480.00 -11.0%2.2%1.6 $4.60 10/30/2020184,000 shares $769,120.00 +7.7%2.5%1.8 $4.18 10/15/2020170,800 shares $845,460.00 -12.7%2.3%1.2 $4.95 9/30/2020195,700 shares $929,575.00 -3.9%2.7%0.8 $4.75 9/15/2020203,700 shares $1.08 million -15.2%2.8%0.1 $5.31 8/31/2020240,100 shares $1.19 million -24.8%3.3%0.1 $4.94 8/14/2020319,100 shares $1.87 million -11.0%4.3%0.1 $5.87 7/31/2020358,700 shares $2.34 million -34.3%4.9%0.1 $6.52 7/15/2020546,200 shares $4.28 million -76.6%7.9%0.2 $7.83 6/30/20202,330,000 shares $16.57 million +692.0%36.0%0.8 $7.11 6/15/2020294,200 shares $1.11 million +20.6%4.5%1.3 $3.78 5/29/2020244,000 shares $861,320.00 -4.6%4.7%1.6 $3.53 5/15/2020255,800 shares $767,400.00 -18.9%4.9%2.5 $3.00 4/30/2020315,200 shares $1.23 million +0.4%6.1%3.6 $3.89 4/15/2020314,000 shares $1.06 million -3.7%6.1%3.7 $3.38 3/31/2020326,100 shares $1.29 million -93.4%6.3%3.9 $3.96 3/13/20204,900,300 shares $13.62 million +5.8%8.0%6.2 $2.78 2/28/20204,630,000 shares $972,300.00 +6.2%7.5%4.3 $0.21 2/14/20204,360,000 shares $1.26 million +6.1%N/A4.4 $0.29 1/31/20204,110,000 shares $1.52 million +30.5%N/A4.4 $0.37 1/15/20203,150,000 shares $1.17 million +15.4%N/A4 $0.37 12/31/20192,730,000 shares $1.04 million -20.6%N/A3.6 $0.38 EKSO Short Interest - Frequently Asked Questions What is Ekso Bionics' current short interest? Short interest is the volume of Ekso Bionics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 73,800 shares of EKSO short. Learn More on Ekso Bionics' current short interest. What is a good short interest ratio for Ekso Bionics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EKSO shares currently have a short interest ratio of 1.0. Learn More on Ekso Bionics's short interest ratio. Is Ekso Bionics' short interest increasing or decreasing? Ekso Bionics saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 73,800 shares, a decrease of 47.8% from the previous total of 141,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ekso Bionics' short interest compare to its competitors? Here is how the short interest of companies compare to Ekso Bionics: Palladyne AI Corp. (3.48%), Richtech Robotics Inc. (9.74%), Fuel Tech, Inc. (0.72%), Tungray Technologies Inc. (0.34%), ZOOZ Power Ltd. (1.62%), SCHMID Group (0.20%), CVD Equipment Co. (0.26%), LiqTech International, Inc. (1.75%), Art's-Way Manufacturing Co., Inc. (0.91%), Nauticus Robotics, Inc. (3.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Ekso Bionics stock? Short selling EKSO is an investing strategy that aims to generate trading profit from Ekso Bionics as its price is falling. EKSO shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ekso Bionics? A short squeeze for Ekso Bionics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EKSO, which in turn drives the price of the stock up even further. How often is Ekso Bionics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EKSO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies PDYN Short Interest Data RR Short Interest Data FTEK Short Interest Data TRSG Short Interest Data ZOOZ Short Interest Data SHMD Short Interest Data CVV Short Interest Data LIQT Short Interest Data ARTW Short Interest Data KITT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EKSO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ekso Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
